Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 8/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 8/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 8/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 8/20 | 0.45 |
| ▸ | PPARG | P37231 | 3/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.33 |
| ▸ | ADAM33 | Q9BZ11 | 2/20 | 0.33 |
| ▸ | MET | P08581 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7312710 | 0.92 | PDE4A (0.42) | PDE4APDE4BPDE4CPDE4DPPARG | |
| SCHEMBL7310209 | 0.92 | PDE4A (0.39) | PDE4APDE4BPDE4CPDE4DPPARG | |
| SCHEMBL7316523 | 0.89 | PDE4A (0.39) | PDE4APDE4BPDE4CPDE4DPPARG | |
| SCHEMBL7317311 | 0.88 | PDE4A (0.42) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7310767 | 0.87 | PDE4A (0.43) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7311023 | 0.83 | PDE4A (0.52) | PDE4APDE4BPDE4CPDE4DITGB3 | |
| SCHEMBL7305497 | 0.83 | PDE4A (0.40) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7318898 | 0.82 | PDE4A (0.38) | PDE4APDE4BPDE4CPDE4DPPARG | |
| SCHEMBL7314035 | 0.81 | LMNA (0.35) | PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7310459 | 0.80 | PDE4A (0.41) | PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4739056-A | ENZYME INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1988-04-19 | — | — | US | disclosed |